NCT07738939 IKS04 Regimen in Advanced Solid Tumors That Express CA242 Status NOT_YET_RECRUITING Phase PHASE1
NCT07729917 Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study Status NOT_YET_RECRUITING Phase PHASE2
NCT07714538 Breath Research Narrow Validation for Gastrointestinal Cancer Detection Status NOT_YET_RECRUITING Phase N/A
NCT07704021 Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation Status COMPLETED Phase N/A
NCT07673341 [18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07641036 Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07623642 A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors. Status NOT_YET_RECRUITING Phase PHASE2
NCT07620080 EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis Status NOT_YET_RECRUITING Phase NA
NCT07619937 Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT07598318 Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT07561775 Adebrelimab Plus S-1 for Resected Cholangiocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07558304 Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial) Status NOT_YET_RECRUITING Phase NA
NCT07556835 Outcomes After Liver and Biliary Resection at a High-Volume Center Status NOT_YET_RECRUITING Phase N/A
NCT07514533 The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07486713 Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies Status RECRUITING Phase PHASE4
NCT07478523 FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers Status RECRUITING Phase PHASE2
NCT07454486 TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort Status NOT_YET_RECRUITING Phase N/A
NCT07359586 Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia Status RECRUITING Phase N/A